Relief Therapeutics Holding AG
RLFTF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $28 | $53 | $15 | $23 |
| - Cash | $13 | $15 | $11 | $15 |
| + Debt | $2 | $2 | $2 | $3 |
| Enterprise Value | $17 | $40 | $7 | $12 |
| Revenue | $1 | $3 | $6 | $3 |
| % Growth | -55.9% | -51.1% | 87.8% | – |
| Gross Profit | $1 | $2 | $4 | -$5 |
| % Margin | 50.8% | 63.3% | 72.4% | -170.8% |
| EBITDA | -$4 | -$14 | -$3 | -$7 |
| % Margin | -329.6% | -508.1% | -44.9% | -220.7% |
| Net Income | -$4 | -$13 | -$5 | -$42 |
| % Margin | -367.7% | -454.7% | -80.6% | -1,384.8% |
| EPS Diluted | -0.36 | -1 | -0.36 | -3.32 |
| % Growth | 64% | -177.8% | 89.2% | – |
| Operating Cash Flow | -$4 | $0 | -$3 | -$7 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$4 | $0 | -$3 | -$7 |